학술논문

Zanubrutinib for the treatment of relapsed/refractory hairy cell leukemia
Document Type
Short Communication
Source
In Blood Advances 27 June 2023 7(12):2884-2887
Subject
Clinical Trials and Observations
Lymphoid Neoplasia
Language
ISSN
2473-9529